The progression of which of the following diseases is retarded by chronic use of enalapril ?
**Core Concept**
The underlying principle being tested involves the use of **angiotensin-converting enzyme inhibitors (ACE inhibitors)** like enalapril in managing diseases related to the **renin-angiotensin-aldosterone system (RAAS)**. This system plays a crucial role in blood pressure regulation and electrolyte balance.
**Why the Correct Answer is Right**
Enalapril, an ACE inhibitor, is known to retard the progression of diseases characterized by **RAAS overactivation**, such as **diabetic nephropathy** and **heart failure**. By inhibiting the conversion of angiotensin I to angiotensin II, enalapril reduces blood pressure and decreases the strain on the heart, thereby slowing disease progression.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while enalapril can manage hypertension, the question asks about retarding disease progression, which is more specific to conditions like diabetic nephropathy or heart failure.
**Option B:** Incorrect as enalapril's primary use is not in retarding the progression of this disease.
**Option C:** Incorrect because enalapril is not primarily used for this condition.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that ACE inhibitors like enalapril are particularly beneficial in patients with **diabetic nephropathy** or **heart failure** due to their ability to reduce proteinuria and slow the progression of renal disease, as well as improve survival in heart failure patients.
**Correct Answer:** D. Diabetic Nephropathy.